Načítá se...
Etanercept (Enbrel(®)) alternative storage at ambient temperature
BACKGROUND: Biologic disease-modifying antirheumatic drugs, including tumor necrosis factor inhibitors such as etanercept (Enbrel(®)), have improved outcomes for patients with rheumatic and other inflammatory diseases, with sustained remission being the optimal goal for patients with rheumatoid arth...
Uloženo v:
| Vydáno v: | Clin Pharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Dove Medical Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5531722/ https://ncbi.nlm.nih.gov/pubmed/28790869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CPAA.S131832 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|